Nicotinamide protected first-phase insulin response (FPIR) and prevented clinical disease in first-degree relatives of type-1 diabetics

Pablo R. Olmos, María I. Hodgson, Alberto Maiz, Mónica Manrique, Marcelo Díaz De Valdés, Rocío Foncea, Ana M. Acosta, Matías V. Emmerich, Soledad Velasco, Osvaldo P. Muñiz, Cristóbal A. Oyarzún, Juan C. Claro, María J. Bastías, Luis A. Toro

Research output: Contribution to journal › Article › peer-review

39 Scopus citations

Fingerprint

Dive into the research topics of 'Nicotinamide protected first-phase insulin response (FPIR) and prevented clinical disease in first-degree relatives of type-1 diabetics'. Together they form a unique fingerprint.

Medicine & Life Sciences